Cortico-basal ganglia connectivity in a non-human primate model of Huntington's disease
亨廷顿病非人类灵长类动物模型中的皮质基底节连接
基本信息
- 批准号:9215293
- 负责人:
- 金额:$ 71.29万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-09-15 至 2021-06-30
- 项目状态:已结题
- 来源:
- 关键词:AffectAnimal ModelAnimalsAreaAtrophicBasal GangliaBehaviorBehavior assessmentBehavioralBiological Neural NetworksBrainBrain regionCAG repeatCell NucleusCharacteristicsChoreaClinicalCognition DisordersCognitiveComplexCorpus striatum structureDARPPDataData SetDendritic SpinesDependovirusDeteriorationDevelopmentDiffusion Magnetic Resonance ImagingDiseaseDisease ProgressionDisease modelDopamineDopamine ReceptorDystoniaElectrophysiology (science)ExhibitsFrightFunctional Magnetic Resonance ImagingFundingFutureGene TransferGenesGliosisGlobus PallidusGlutamate ReceptorGlutamatesGlutamineGoalsHistological TechniquesHumanHuntington DiseaseHuntington geneImageImpaired cognitionInclusion BodiesInjection of therapeutic agentInterventionK-Series Research Career ProgramsLaboratoriesLeadLengthMacacaMacaca mulattaMagnetic Resonance ImagingManuscriptsMediatingModelingMolecularMonkeysMorphologyMotorMotor CortexMotor SkillsMovement DisordersMutationNational Institute of Neurological Disorders and StrokeNerve DegenerationNeurobiologyNeurodegenerative DisordersNeuronal DysfunctionNeuronsNeurosciencesPathologyPatientsPhenotypePreparationProteinsResearchRestScientistShort-Term MemorySliceStatistical Data InterpretationStretchingStructureSubstantia nigra structureTechniquesTechnologyTestingTherapeutic Use StudyTranscriptadeno-associated viral vectorastrogliosiscognitive developmentdisease phenotypeexecutive functionexperiencefrontal lobegain of functionimage guidedin vivomotor controlmotor disordermutantneuroimagingneuron lossneuropathologyneurosurgeryneurotransmissionnonhuman primatenovelputamentouchscreentransmission processvector genomewhite matter
项目摘要
PROJECT SUMMARY
The goal of the proposed research in this application is to characterize alterations in cortico-basal ganglia
connectivity in a novel non-human primate model of Huntington's disease (HD) recently developed in my
laboratory. Previous K99/R00 funding (2010-2015) from the NINDS supported the development of this new
model, wherein we found that AAV-mediated expression of mutant HTT in the caudate and putamen of rhesus
macaques lead to a wide array of behavioral manifestations of disease including the progressive development
of both motor and cognitive phenotypes also seen in human HD patients. Brains from HD NHPs showed
DARPP-32 loss, inclusion formation and gliosis, along with reduced levels of key striatal transcripts, including
reduced glutamate and dopamine receptor levels (manuscript in preparation). In addition to striatal pathology,
we found mHTT expression, inclusion bodies and gliosis in numerous cortical areas (frontal and motor) and
regions throughout the basal ganglia (globus pallidus, substantia nigra), likely owing to transport of the AAV
vector. These findings strongly suggest that basal ganglia connectivity may be disrupted in our NHP HD model.
The objective of this current proposal is to characterize cortico-basal ganglia connectivity in the brains of our
HD NHPs using resting state fMRI and diffusion tensor imaging to assess functional connectivity and white
matter integrity, respectively (Aim 1). Additionally, we will evaluate glutamate and dopamine neurotransmission
in the caudate and putamen using electrophysiological analyses (Aim 2). We will test our central hypothesis
that there is a progressive decline in basal ganglia connectivity in our HD NHP brains that correlates with 1) the
longitudinal development of cognitive and motor phenotypes, 2) reduced glutamate and dopamine
transmission in cortico-striatal and nigro-striatal connections with medium spiny neurons in the caudate and
putamen and 3) neuropathology including inclusion formation, gliosis and neuronal dysfunction. I have
assembled an excellent team of scientists to accomplish these goals with cumulative expertise in resting state
fMRI analysis of cortico-striatal functional connectivity (Dr. Christopher Kroenke), electrophysiological
recordings of medium spiny neurons in the rhesus macaque striatum (Dr. Verginia Cuzon Carlson), statistical
analysis of complex datasets (Dr. Byung Park), as well as my background and expertise in HD neurobiology,
AAV-mediated gene transfer, NHP MRI-guided neurosurgery, complex NHP motor and cognitive behavioral
assessment and the use of molecular and histological techniques to assess HD neuropathology. By the end of
the studies proposed here, we will have characterized alterations in basal ganglia connectivity in a novel AAV-
mHTT mediated monkey model of HD, elucidating potential pathophysiological mechanisms that underlie
motor and cognitive decline. Additionally, the data obtained from these studies will provide the unique
opportunity to identify imaging, behavioral, electrophysiological and neuropathological endpoints that will be
used for future therapeutic studies using this model.
项目概要
本申请中拟议研究的目标是表征皮质基底神经节的变化
我最近开发的一种新型非人类灵长类亨廷顿病(HD)模型中的连通性
实验室。 NINDS 之前的 K99/R00 资金(2010-2015 年)支持了这一新产品的开发
模型中,我们发现 AAV 介导的恒河猴尾状核和壳核中突变型 HTT 的表达
猕猴会导致一系列疾病的行为表现,包括逐渐发展
在人类 HD 患者中也观察到了运动和认知表型的变化。 HD NHP 的大脑显示
DARPP-32 丢失、包含物形成和神经胶质增生,以及关键纹状体转录物水平降低,包括
谷氨酸和多巴胺受体水平降低(手稿正在准备中)。除了纹状体病理学之外,
我们在许多皮质区域(额叶和运动区域)发现了 mHTT 表达、包涵体和神经胶质增生,
整个基底神经节区域(苍白球、黑质),可能是由于 AAV 的运输
向量。这些发现强烈表明,我们的 NHP HD 模型中基底神经节的连接可能会受到破坏。
当前提案的目标是表征我们大脑中的皮质基底神经节连接性
HD NHP 使用静息态 fMRI 和扩散张量成像来评估功能连接和白
分别是物质完整性(目标 1)。此外,我们将评估谷氨酸和多巴胺神经传递
使用电生理学分析对尾状核和壳核进行观察(目标 2)。我们将检验我们的中心假设
我们的 HD NHP 大脑中基底神经节连接性逐渐下降,这与 1)
认知和运动表型的纵向发展,2)谷氨酸和多巴胺减少
皮质纹状体和黑质纹状体与尾状核和中型多棘神经元连接的传递
壳核和 3) 神经病理学,包括包涵体形成、神经胶质增生和神经元功能障碍。我有
组建了一支优秀的科学家团队,通过在静息状态下积累的专业知识来实现这些目标
皮质纹状体功能连接的 fMRI 分析(Christopher Kroenke 博士)、电生理学
恒河猴纹状体中型多刺神经元的记录(Verginia Cuzon Carlson 博士),统计
复杂数据集的分析(Byung Park 博士),以及我在 HD 神经生物学方面的背景和专业知识,
AAV 介导的基因转移、NHP MRI 引导的神经外科手术、复杂的 NHP 运动和认知行为
评估以及使用分子和组织学技术来评估 HD 神经病理学。到年底
根据这里提出的研究,我们将描述一种新型 AAV- 中基底神经节连接的变化
mHTT 介导的 HD 猴子模型,阐明潜在的病理生理机制
运动和认知能力下降。此外,从这些研究中获得的数据将提供独特的
有机会识别影像学、行为学、电生理学和神经病理学终点
用于使用该模型的未来治疗研究。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jodi L. McBride其他文献
Jodi L. McBride的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jodi L. McBride', 18)}}的其他基金
SYSTEMIC DELIVERY RNA INTERFERENCE USING AAV9; TREAT HUNTINGTON'S DISEASE
使用 AAV9 进行全身性 RNA 干扰;
- 批准号:
8357871 - 财政年份:2011
- 资助金额:
$ 71.29万 - 项目类别:
RNAi therapy for Huntingtons disease: safety & efficacy in the nonhuman primate
亨廷顿病的 RNAi 疗法:安全性
- 批准号:
8270977 - 财政年份:2011
- 资助金额:
$ 71.29万 - 项目类别:
RNAI THERAPY FOR HUNTINGTONS DISEASE: SAFEY & EFFICACY IN THE NONHUMAN PRIMATE
亨廷顿病的 RNAI 疗法:安全
- 批准号:
8357870 - 财政年份:2011
- 资助金额:
$ 71.29万 - 项目类别:
RNAi therapy for Huntingtons disease: safety & efficacy in the nonhuman primate
亨廷顿病的 RNAi 疗法:安全性
- 批准号:
8478217 - 财政年份:2010
- 资助金额:
$ 71.29万 - 项目类别:
RNAi therapy for Huntingtons disease: safety & efficacy in the nonhuman primate
亨廷顿病的 RNAi 疗法:安全性
- 批准号:
8279303 - 财政年份:2010
- 资助金额:
$ 71.29万 - 项目类别:
RNAi therapy for Huntingtons disease: safety & efficacy in the nonhuman primate
亨廷顿病的 RNAi 疗法:安全性
- 批准号:
7873076 - 财政年份:2010
- 资助金额:
$ 71.29万 - 项目类别:
Non-alledle specific RNAi as a potential therapy for Huntington's disease
非等位基因特异性 RNAi 作为亨廷顿病的潜在疗法
- 批准号:
7489861 - 财政年份:2007
- 资助金额:
$ 71.29万 - 项目类别:
Non-alledle specific RNAi as a potential therapy for Huntington's disease
非等位基因特异性 RNAi 作为亨廷顿病的潜在疗法
- 批准号:
7329703 - 财政年份:2007
- 资助金额:
$ 71.29万 - 项目类别:
相似国自然基金
肾—骨应答调控骨骼VDR/RXR对糖尿病肾病动物模型FGF23分泌的影响及中药的干预作用
- 批准号:82074395
- 批准年份:2020
- 资助金额:55 万元
- 项目类别:面上项目
基于细胞自噬调控的苦参碱对多囊肾小鼠动物模型肾囊肿形成的影响和机制研究
- 批准号:
- 批准年份:2019
- 资助金额:33 万元
- 项目类别:地区科学基金项目
靶向诱导merlin/p53协同性亚细胞穿梭对听神经瘤在体生长的影响
- 批准号:81800898
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
NRSF表达水平对抑郁模型小鼠行为的影响及其分子机制研究
- 批准号:81801333
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
伪狂犬病病毒激活三叉神经节细胞对其NF-кB和PI3K/Akt信号转导通路影响的分子机制研究
- 批准号:31860716
- 批准年份:2018
- 资助金额:39.0 万元
- 项目类别:地区科学基金项目
相似海外基金
A National NHP Embryo Resource of Human Genetic Disease Models
国家NHP人类遗传病模型胚胎资源
- 批准号:
10556087 - 财政年份:2023
- 资助金额:
$ 71.29万 - 项目类别:
Chronic Pain and Risk of Alzheimer's-Related Neurodegeneration
慢性疼痛和阿尔茨海默病相关神经变性的风险
- 批准号:
10644253 - 财政年份:2023
- 资助金额:
$ 71.29万 - 项目类别:
An Integrated Catheter Dressing for Early Detection of Catheter-related Bloodstream Infections
用于早期检测导管相关血流感染的集成导管敷料
- 批准号:
10647072 - 财政年份:2023
- 资助金额:
$ 71.29万 - 项目类别: